Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Diabetes Obes Metab. 2011 Nov 21;14(3):279–282. doi: 10.1111/j.1463-1326.2011.01520.x

Figure 2.

Figure 2

ACVR2B:Fc treatment for 12 weeks does not affect glucose tolerance (A), fasting blood glucose (B), or fed insulin (C) in mice fed a HFD for 12 weeks before and after treatment. Data are shown as mean ± SEM. Data are not significant by student’s t test and repeated measures ANOVA.